EBS
Price
$7.17
Change
-$0.30 (-4.02%)
Updated
Jul 25 closing price
Capitalization
120.07M
11 days until earnings call
HKMPF
Price
$27.96
Change
+$1.16 (+4.33%)
Updated
Jul 24 closing price
Capitalization
5.93B
Interact to see
Advertisement

EBS vs HKMPF

Header iconEBS vs HKMPF Comparison
Open Charts EBS vs HKMPFBanner chart's image
Emergent Biosolutions
Price$7.17
Change-$0.30 (-4.02%)
Volume$788.62K
Capitalization120.07M
Hikma Pharmaceuticals
Price$27.96
Change+$1.16 (+4.33%)
Volume$123
Capitalization5.93B
EBS vs HKMPF Comparison Chart in %
Loading...
EBS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HKMPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EBS vs. HKMPF commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EBS is a Hold and HKMPF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (EBS: $7.17 vs. HKMPF: $27.96)
Brand notoriety: EBS and HKMPF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: EBS: 73% vs. HKMPF: 106%
Market capitalization -- EBS: $120.07M vs. HKMPF: $5.93B
EBS [@Pharmaceuticals: Other] is valued at $120.07M. HKMPF’s [@Pharmaceuticals: Other] market capitalization is $5.93B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.83B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EBS’s FA Score shows that 1 FA rating(s) are green whileHKMPF’s FA Score has 1 green FA rating(s).

  • EBS’s FA Score: 1 green, 4 red.
  • HKMPF’s FA Score: 1 green, 4 red.
According to our system of comparison, EBS is a better buy in the long-term than HKMPF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EBS’s TA Score shows that 2 TA indicator(s) are bullish while HKMPF’s TA Score has 4 bullish TA indicator(s).

  • EBS’s TA Score: 2 bullish, 5 bearish.
  • HKMPF’s TA Score: 4 bullish, 0 bearish.
According to our system of comparison, HKMPF is a better buy in the short-term than EBS.

Price Growth

EBS (@Pharmaceuticals: Other) experienced а +3.46% price change this week, while HKMPF (@Pharmaceuticals: Other) price change was +0.83% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.51%. For the same industry, the average monthly price growth was +11.90%, and the average quarterly price growth was +74.65%.

Reported Earning Dates

EBS is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+3.51% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HKMPF($5.93B) has a higher market cap than EBS($120M). HKMPF has higher P/E ratio than EBS: HKMPF (31.65) vs EBS (17.73). HKMPF YTD gains are higher at: 18.084 vs. EBS (-25.000). HKMPF has higher annual earnings (EBITDA): 489M vs. EBS (-518.2M). HKMPF has more cash in the bank: 292M vs. EBS (112M). EBS has less debt than HKMPF: EBS (860M) vs HKMPF (1.28B). HKMPF has higher revenues than EBS: HKMPF (2.52B) vs EBS (1.02B).
EBSHKMPFEBS / HKMPF
Capitalization120M5.93B2%
EBITDA-518.2M489M-106%
Gain YTD-25.00018.084-138%
P/E Ratio17.7331.6556%
Revenue1.02B2.52B41%
Total Cash112M292M38%
Total Debt860M1.28B67%
FUNDAMENTALS RATINGS
EBS vs HKMPF: Fundamental Ratings
EBS
HKMPF
OUTLOOK RATING
1..100
889
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
17
Undervalued
PROFIT vs RISK RATING
1..100
10091
SMR RATING
1..100
9490
PRICE GROWTH RATING
1..100
5751
P/E GROWTH RATING
1..100
1191
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HKMPF's Valuation (17) in the null industry is somewhat better than the same rating for EBS (56) in the Biotechnology industry. This means that HKMPF’s stock grew somewhat faster than EBS’s over the last 12 months.

HKMPF's Profit vs Risk Rating (91) in the null industry is in the same range as EBS (100) in the Biotechnology industry. This means that HKMPF’s stock grew similarly to EBS’s over the last 12 months.

HKMPF's SMR Rating (90) in the null industry is in the same range as EBS (94) in the Biotechnology industry. This means that HKMPF’s stock grew similarly to EBS’s over the last 12 months.

HKMPF's Price Growth Rating (51) in the null industry is in the same range as EBS (57) in the Biotechnology industry. This means that HKMPF’s stock grew similarly to EBS’s over the last 12 months.

EBS's P/E Growth Rating (11) in the Biotechnology industry is significantly better than the same rating for HKMPF (91) in the null industry. This means that EBS’s stock grew significantly faster than HKMPF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EBSHKMPF
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
26%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
44%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
45%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
36%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
37%
Advances
ODDS (%)
Bullish Trend 4 days ago
76%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
EBS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HKMPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FMCCL17.810.06
+0.32%
Freddie Mac
EBKDY46.260.11
+0.24%
Erste Group Bank AG
GRVWF0.28N/A
N/A
Greatview Aseptic Packaging Company Ltd.
NPTLF10.00N/A
N/A
NORTHAM PLATINUM HLDGS LTD.
TOEYF0.09-0.02
-21.25%
Toro Energy Ltd.

EBS and

Correlation & Price change

A.I.dvisor indicates that over the last year, EBS has been loosely correlated with AMRX. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if EBS jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EBS
1D Price
Change %
EBS100%
-4.02%
AMRX - EBS
40%
Loosely correlated
+0.75%
HROW - EBS
39%
Loosely correlated
-2.81%
SIGA - EBS
34%
Loosely correlated
+1.13%
HKMPF - EBS
34%
Loosely correlated
N/A
VTRS - EBS
33%
Loosely correlated
+0.64%
More

HKMPF and

Correlation & Price change

A.I.dvisor indicates that over the last year, HKMPF has been loosely correlated with EBS. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if HKMPF jumps, then EBS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HKMPF
1D Price
Change %
HKMPF100%
N/A
EBS - HKMPF
34%
Loosely correlated
-4.02%
IRWD - HKMPF
22%
Poorly correlated
-5.87%
AMPH - HKMPF
22%
Poorly correlated
-1.15%
GRUSF - HKMPF
8%
Poorly correlated
N/A
HYPMY - HKMPF
7%
Poorly correlated
-4.52%
More